EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY-NC-ND 4.0

Current Landscape of iPSC Haplobanks

Rubén Escribá, Meral Beksac, Annelise Bennaceur-Griscelli, Joel C Glover, Satu Koskela, Helen Latsoudis, Sergi Querol, Belén Alvarez-Palomo iD

Stem Cell Reviews and Reports · 2024

DOI: 10.1007/s12015-024-10783-7 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Stem Cell Reviews and Reports, 2024. Verfasst von Rubén Escribá und 7 weiteren Autor:innen. Beteiligte Einrichtung: Cell Therapy Service, Banc de Sang I Teixits, 106 Passeig de Taulat, 08005, Barcelona, Spain. Hauptthemen laut MEDLINE: Induced Pluripotent Stem Cells, Haplotypes. Die Arbeit wurde bisher 25-mal zitiert (Crossref) und nennt 70 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: European Cooperation in Science and Technology.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

The use of allogeneic induced pluripotent stem cell (iPSC)-derived cell therapies for regenerative medicine offers an affordable and realistic alternative to producing individual iPSC lines for each patient in need. Human Leukocyte Antigens (HLA)-homozygous iPSCs matched in hemi-similarity could provide cell therapies with reduced immune rejection covering a wide range of the population with a few iPSC lines. Several banks of HLA-homozygous iPSCs (haplobanks) have been established worldwide or are underway, to provide clinical grade starting material for cell therapies covering the most frequent HLA haplotypes for certain populations. Harmonizing quality standards among haplobanks and creating a global registry could minimize the collective effort and provide a much wider access to HLA-compatible cell therapies for patients with less frequent haplotypes. In this review we present all the current haplobank initiatives and their potential benefits for the global population.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Induced Pluripotent Stem CellsHaplotypesHumansHLA AntigensRegenerative MedicineCell- and Tissue-Based Therapy

Stichwörter der Autor:innen

HLA-homozygousHLA-matchHaplobanksInduced pluripotent stem cellsRegenerative medicine

Substanzen

HLA Antigens

Autor:innen und Institutionen

  • Cell Therapy Service, Banc de Sang I Teixits, 106 Passeig de Taulat, 08005, Barcelona, Spain.
  • Ankara Liv Hospital Istinye University and Cord Blood Bank, Ankara University, Ankara, Turkey.
  • CiTHERA, Center of iPS Cell Therapy, Infrastructure INGESTEM University Paris Saclay Inserm U1310, 28 Rue Henri Desbruères, 91100, Corbeil-Essonnes, France.
  • Norwegian Center for Stem Cell Research and Norwegian Core Facility for Human Pluripotent Stem Cells, Department of Immunology and Transfusion Medicine, Oslo University Hospital, Oslo, Norway.
  • Finnish Red Cross Blood Service Biobank, Härkälenkki 13, 01730, Vantaa, Finland.
  • Information Systems Laboratory, Institute of Computer Sciences, Foundation for Research and Technology Hellas, 70013, Heraklion, Crete, Greece.

ORCID-Profile: Belén Alvarez-Palomo

Förderung

  • European Cooperation in Science and Technology

Zitieren

APA

Escribá, R., Beksac, M., Bennaceur-Griscelli, A., Glover, J. C., Koskela, S., Latsoudis, H., Querol, S., & Alvarez-Palomo, B. (2024). Current Landscape of iPSC Haplobanks. Stem Cell Reviews and Reports. https://doi.org/10.1007/s12015-024-10783-7

Vancouver

Escribá R, Beksac M, Bennaceur-Griscelli A, Glover JC, Koskela S, Latsoudis H, et al. Current Landscape of iPSC Haplobanks. Stem Cell Reviews and Reports. 2024. doi:10.1007/s12015-024-10783-7

BibTeX
@article{Escrib2024,
  author = {Escribá, Rubén and Beksac, Meral and Bennaceur-Griscelli, Annelise and Glover, Joel C and Koskela, Satu and Latsoudis, Helen and Querol, Sergi and Alvarez-Palomo, Belén},
  title = {Current Landscape of iPSC Haplobanks},
  journal = {Stem Cell Reviews and Reports},
  year = {2024},
  doi = {10.1007/s12015-024-10783-7}
}
Kostenlos starten →